In the intensive care unit (ICU), arterial pressure was 80/50 mmHg and respiratory rate was 26/min. The heart rate was 126 bpm. Cardiovascular examination revealed a Grade 4-5/6 pansystolic murmur at the cardiac apex. Transthoracic echocardiography demonstrated dilated cardiomegaly with a prominent trabecular meshwork and deep intertrabecular spaces (Figure 1). Cardiac enzymes were normal. Twodimensional and Doppler echocardiography revealed an enlarged left atrium, and a dilated LV with a poor systolic function LV ejection fraction of 22%. There was severe mitral valve regurgitation and mild tricuspid valve regurgitation (Figure 2). The ratio of the non-compacted-to-compacted myocardial layers was 2.90 (>2.0). We performed coronary angiography and cardiac catheterization. There was a hypertrabeculated LV which constituted deep myocardial recesses (Figure 3). To relieve the symptoms, medication including levosimendan infusion was started in the ICU. Two weeks later, there was no symptom. However, no recovery of myocardial dysfunction and severe mitral valvular regurgitation were observed. Mitral valve repair was recommended to the patient.
A written informed consent was obtained from the patient. Using a midline sternotomy, aortic and venous cannulation was performed. Intraoperative findings showed severe mitral valve regurgitation and severe myxoid degeneration. We observed non-compacted endomyocardium, and LV deep recesses. Mitral valve repair was performed and a mitral valve ring was replaced. Tricuspid annuloplasty was also performed using a flexible ring. The patient was discharged in a good clinical condition without any symptom. Six months later, she was still symptom-free and echocardiography showed that LV ejection fraction increased to 45% and a pulmonary artery pressure decreased to normal range.
Gati et al.[2] demonstrated that the development of de novo LVNC i n 2 5% o f 102 p rimigravida w omen with an age ranging between 18 and 35 years who had no evidence of LVNC or another cardiac disease in the pre-pregnancy period. In the postpartum period, they found that 18 women showed complete resolution of LV trabeculation within six months. In addition, spontaneous recovery of myocardial dysfunction in 7% of cases with LVNC was reported by Ali et al.[6] and Gati et al.,[2] suggested that the pregnancy induced de novo LV trabeculations due to LV volume overload and certain physiopathological responses. However, no patient with severe valvular heart disease has been reported previously. Therefore, to the best of our knowledge, there has been no report with cardiomyopathy accompanied by LVNC and severe mitral regurgitation after pregnancy in the literature.
The triad of LVNC is described by heart failure, arrhythmias, and embolic events which are the major clinical manifestations in patients with reduced systolic LV function. Our case was also admitted to our hospital due to LV systolic and diastolic dysfunction and sinus tachycardia.
Echocardiography is accepted as a definitive standard for the diagnosis of LVNC.[3,5-7] Magnetic resonance imaging and left ventriculography can be also used to identify subendocardial perfusion deficits and hypertrabeculation with deep recesses.
A largest series showed that 35% of patients with LVNC died due to sudden cardiac death.[8] A total of 12% of patients also underwent heart transplantation in the long-term follow-up period.[9,10] Thromboembolic events and ventricular tachycardia are the cause of poor clinical prognosis of these patients with impaired LV function. In addition, a higher LV end-diastolic diameter at the time of initial presentation, New York Heart Association Class III/IV, chronic atrial fibrillation, and bundle branch block are the most common findings of non-survivors.[6-8]
The treatment strategies of patients with LVNC are similar to that of patients with other cardiomyopathies. Appropriate treatment includes management of arrhythmias, and oral anticoagulation to prevent systemic embolism in patients with impaired LV function.[9,11] Early l isting of symptomatic patients for heart transplantation must be seriously considered. Therefore, we performed mitral valve repair and tricuspid annuloplasty following medical management with levosimendan infusion in our case. In the literature, severe cardiovascular complications have been described.[9]
In conclusion, we suggest that pregnancy may induce de novo left ventricular non-compaction. Progressive cardiomyopathy may develop in puerperium without any cardiovascular disease such as heart valve regurgitation. As de novo left ventricular non-compaction with symptomatic cardiomyopathy accompanied by valvular heart disease has a high mortality rate, pregnants should be followed closely and appropriate medical management should be considered. Our case with cardiomyopathy due to de novo l eft v entricular n on-compaction is the first postpartum case who underwent mitral and tricuspid valve surgery in the literature.
Declaration of conflicting interests
The authors declared no conflicts of interest with respect to
the authorship and/or publication of this article.
Funding
The authors received no financial support for the research
and/or authorship of this article.
1) Abboud J, Murad Y, Chen-Scarabelli C, Saravolatz L,
Scarabelli TM. Peripartum cardiomyopathy: a comprehensive
review. Int J Cardiol 2007;118:295-303.
2) Gati S, Papadakis M, Papamichael ND, Zaidi A, Sheikh
N, Reed M, et al. Reversible de novo left ventricular
trabeculations in pregnant women: implications for the
diagnosis of left ventricular noncompaction in low-risk
populations. Circulation 2014;130:475-83.
3) Engberding R, Bender F. Identification of a rare congenital
anomaly of the myocardium by two-dimensional
echocardiography: persistence of isolated myocardial
sinusoids. Am J Cardiol 1984:1;53:1733-4.
4) Dogan R, Dogan OF, Oc M, Duman U, Ozkutlu S, Celiker
A. Noncompaction of ventricular myocardium in a patient
with congenitally corrected transposition of the great
arteries treated surgically: case report. Heart Surg Forum
2005;8:E110-3.
5) Doğan ÖF, Demircin M. Successsful closure of ventricular
septal defect in a patient with non-compaction of the
left ventricular myocardium. Turk Gogus Kalp Dama
2008;16:257-259.
6) Ali SK, Omran AS, Najm H, Godman MJ. Noncompaction
of the ventricular myocardium associated with mitral
regurgitation and preserved ventricular systolic function.
J Am Soc Echocardiogr 2004;17:87-90.
7) Ali SK. Noncompaction of the ventricular myocardium,
mitral regurgitation, and recovery of myocardial function:
the missing link? Ann Thorac Surg 2011;91:985-6.
8) Chung JW, Lee SJ, Lee JH, Chin JY, Lee HJ, Lee CJ, et
al. Isolated left ventricular noncompaction cardiomyopathy
accompanied by severe mitral regurgitation. Korean Circ J
2009;39:494-8.
9) Stamou SC, Lefrak EA, Athari FC, Burton NA, Massimiano
PS. Heart transplantation in a patient with isolated
noncompaction of the left ventricular myocardium. Ann
Thorac Surg 2004;77:1806-8.